ARTIMPLANT INTERIM REPORT JANUARY - MARCH 2008

Västra Frölunda, Sweden, May 6, 2008

• Net revenue for the first quarter amounted to SEK 2.1 million (3.9)*
• The net loss for the first quarter totaled SEK -6.2 million (-2.9)
• Earnings per share for the first quarter amounted to SEK -0.10 (-0.05)
• Sales of Artelon® Spacer totaled approximately 800 (1,300) units
• Over 7,000 patients were treated with Artelon® implants up to and including the first quarter of 2008
• Positive clinical experience from soft tissue treatment using Artelon® – a decision has been taken to commence the pre-launch of Artelon® Cosmetic in dental applications
• New sales management recruited for Artimplant USA, Inc.

Event after the period-end
• An agreement was signed regarding a clinical pilot study for the treatment of osteoarthritis in the facet joints in the spine

N.B. This is a translation from Swedish. The Swedish version shall always take precedence.

Artimplant will present this report at the Annual Meeting on May 6, 2008, at 5pm, Central European Time (GMT+1). The presentation will be published on the Company's website after the meeting. No telephone conference will be held by reason of this report. For further information and full interim report see www.artimplant.com.

* Figures in brackets refer to the corresponding period last year